Legeviten > Oftalmologi
|
Fired by the 'Captain of Industry'.
Les mer »
An employee being terminated deserves some level of respect.
(MedPage Today) |
|
EndoBreak: Meet the 'Sugar Sponge'; Alleged Murder by Insulin.
Les mer »
News and commentary from the endocrinology world.
(MedPage Today) |
Anti-VEGF for Diabetic Retinopathy: A 'Strong Option'.
Les mer »
But barriers still prevent wide clinical implementation.
(MedPage Today) |
|
Eyeing the Death of a Cell.
Les mer »
Researchers image single cell deaths in glaucoma patients.
(MedPage Today) |
|
Medicare Fraud Conviction for Retina Surgeon.
Les mer »
Earlier this month, a jury convicted West Palm Beach retina surgeon Solomon Melgen, MD, on 67 counts of Medicare fraud.
(MedPage Today) |
The Importance of Being Honest.
Les mer »
Ophthalmologists need to be upfront with patients - and themselves.
(MedPage Today) |
|
NRTIs: New Frontier in AMD.
Les mer »
Antiviral agents show promise for macular degeneration, including dry form.
(MedPage Today) |
Rise of the Machines: Progress or Replacing MDs?
Les mer »
Medicine -- including ophthalmology -- has come a long way over the past century, driven by brilliant and committed people and better technology.
(MedPage Today) |
|
Reviewing VEGF Results in DME: Ophthalmology Times.
Les mer »
Also: minimally invasive technique may be good option for glaucoma.
(MedPage Today) |
Anti-VEGF Injections Bring on Eye Anxiety.
Les mer »
Many patients report stress from intravitreal treatments.
(MedPage Today) |
|
Telemedicine Ups Diabetic Retinopathy Screening.
Les mer »
Earn Free CME Credits by reading the latest medical news in your specialty.
(MedPage Today) |
William Shatners Priceline.com Hollywood Charity Horse Show Sponsored by Wells Fargo Returns June 3 with Special Musical Guest Nancy Wilsons Roadcase Royale.
Les mer »
For nearly three decades, prominent actor and equine lover William Shatner has taken on perhaps his most significant role, not on TV or in film, but in real life as a tireless advocate for underrepresented communities, raising tens of millions of dollars to support hundreds of worthy charitable organizations by way of his annual philanthropic horse show event.
(www.digitalproducer.com) |
|
Gene Therapy for Age-Related Macular Degeneration Safe in Humans.
Les mer »
A small Phase I clinical trial reports that, even at high doses, the treatment did not lead to adverse reactions.
(The Scientist) |
Ms. Lauren P. Silvernail appointed to Nicox Board of Directors.
Les mer »
Ms. Lauren P. Silvernail appointed to Nicox Board of Directors.
(inpublic.globenewswire.com) |
|
Anna Midelfart - Æresmedlem i LVS.
Les mer »
Ved LVS-årsmøte 2017, ble Anna Midelfart, som var initiativtaker for å etablere LVS i 1990, utnevnt til æresmedlem. Her kan du lese talen Helge Bjørnstad-Pettersen holdt for Anna i denne forbindelse.
(Den norske l?geforening) |
Eyeing Disease Spread in Donor Corneas: Ophthalmology Times.
Les mer »
Also, what are the risks of corneal crosslinking?
(MedPage Today) |
|
Nicox announces the presentation of scientific data on NCX 667 at ARVO 2017.
Les mer »
Nicox announces the presentation of scientific data on NCX 667 at ARVO 2017.
(inpublic.globenewswire.com) |
Nicox annonce la présentation de données scientifiques sur le NCX 667 au congrès ARVO 2017.
Les mer »
Nicox annonce la présentation de données scientifiques sur le NCX 667 au congrès ARVO 2017.
(inpublic.globenewswire.com) |
|
CDR-Life Announces Formation of Scientific Advisory Board.
Les mer »
Inaugural Members Include Leading Ophthalmic Luminaries from the United States and Europe.
(www.digitalproducer.com) |
GenSight Biologics to Present Data on GS010 and GS030 at the Annual Meeting of ARVO.
Les mer »
GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company that discovers and develops innovative gene therapies for neurodegenerative retinal diseases and diseases of the central nervous system.
(www.digitalproducer.com) |
|
Ocular Therapeutix Reports First Quarter 2017 Financial Results.
Les mer »
PDUFA Target Action Date of July 19, 2017 for the DEXTENZA NDA for the Treatment of Ocular Pain Following Ophthalmic Surgery; Commercial Launch Preparation Activities Underway.
(www.digitalproducer.com) |
Envisia Therapeutics To Present New Data At ARVO 2017 Annual Meeting.
Les mer »
Company to Deliver Seven Data Presentations at World's Largest International Ophthalmology Gathering.
(www.digitalproducer.com) |
|
Why are We Straining to Communicate?
Les mer »
In the 21st century, things can -- and should -- work better.
(MedPage Today) |
Thyroid Disease Linked With Uveitis.
Les mer »
The conditions may share a common autoimmune pathophysiology.
(MedPage Today) |
|
The 8 Worst Things You Can Do To Your Eyes.
Les mer »
They’re the only pair you’ll get—so you want to keep them safe.
(www.bicycling.com) |
|
Envisia Therapeutics To Present New Data On Lead Programs At ASCRS 2017 Annual Meeting.
Les mer »
Company to Deliver Key Data Presentations at the Pre-Eminent Meeting for Ophthalmologists Specializing in Anterior Segment.
(www.digitalproducer.com) |
Anti-TNF Seems to Boost Visual Functioning in Uveitis.
Les mer »
Earn Free CME Credits by reading the latest medical news in your specialty.
(MedPage Today) |
|
Bonti Announces Hot Topics Presentation of Phase 2a Interim Clinical Data at The Aesthetic Meeting 2017.
Les mer »
Investigational Product EB-001 and Co-principal Investigator Dr. Steve Yoelin Spotlighted at Premier Global Session on April 28 th in San Diego, CA.
(www.digitalproducer.com) |
Pixium Vision and research partners report progress in multiple areas with IRIS® and PRIMA during ARVO 2017 World Conference.
Les mer »
® system shows highly significant correlation between electrode stimulation site and visual percept location.
(www.digitalproducer.com) |
|
Emerging Therapies for Uveal Melanoma: Ophthalmology Times.
Les mer »
Also: avoiding ruptures during deep anterior lamellar keratoplasty.
(MedPage Today) |
|
Repeated Intravitreal Injections Linked to Glaucoma.
Les mer »
7 or more bevacizumab injections per year may double risk of glaucoma surgery.
(MedPage Today) |
|
ProQR to Present its Ophthalmology Pipeline at ARVO, Highlighting Programs in Lebers Congenital Amaurosis Type 10 and Usher Syndrome.
Les mer »
At ARVO ProQR will present additional positive pre-clinical proof-of-concept data for QR-110 targeting LCA 10. The company has recently received IND clearance to start clinical trials for this program in both adult and pediatric patients.
(www.digitalproducer.com) |
|
RXi Pharmaceuticals Corporation Selected to Present at the Cavendish Global Health Impact Forum.
Les mer »
Forum brings together leading family offices, foundations and impact investors seeking impact investment, grant-giving, and philanthropy opportunities within health and life sciences.
(www.digitalproducer.com) |
Ascendis Pharma A/S Announces Upcoming Investor Presentations.
Les mer »
COPENHAGEN, Denmark, April 28, 2017 /PRNewswire/ -- Ascendis Pharma A/S, a biopharmaceutical company that utilizes its innovative TransCon technology to address significant unmet medical needs in rare diseases, today announced that the company will participate in two upcoming investor conferences in May.
(www.digitalproducer.com) |
|
Ozanimod Keeps on Working in MS Extension Trial.
Les mer »
Placebo patients switched to the investigative agent catch up in lowering relapse rate.
(MedPage Today) |
27/04-2017 21:30:18: Dr. Oh Unveils Innovative '2Day LASEK' Eye Surgery.
Les mer »
The surgical procedure for 2Day LASEK Eye Surgery, featuring 40-percent less damage area, revealed to the world.
(Netfonds) |
|Om Viddi.no | Kontakt oss på support (a) viddi.no | Copyright® - 2006 Viddinews AS |